Patricio Polanco is a Surgical Oncologist and a General Surgeon in Dallas, Texas. Dr. Polanco is rated as an Elite provider by MediFind in the treatment of Pancreatic Cancer. His top areas of expertise are Pancreatic Cancer, Colorectal Cancer, Neuroendocrine Tumor, Pancreatectomy, and Pancreaticoduodenectomy.

Ching-wei Tzeng is a Surgical Oncologist in Houston, Texas. Dr. Tzeng is rated as an Elite provider by MediFind in the treatment of Pancreatic Cancer. His top areas of expertise are Pancreatic Cancer, Cholangiocarcinoma (Bile Duct Cancer), Pancreatic Ductal Adenocarcinoma, Hepatectomy, and Pancreatectomy.

Eugene Koay is a Radiation Oncologist in Houston, Texas. Dr. Koay has been practicing medicine for over 17 years and is rated as an Elite provider by MediFind in the treatment of Pancreatic Cancer. His top areas of expertise are Pancreatic Cancer, Pancreatic Ductal Adenocarcinoma, Cholangiocarcinoma (Bile Duct Cancer), Pancreaticoduodenectomy, and Pancreatectomy.

Richard Tuli is a Radiation Oncologist in San Antonio, Texas. Dr. Tuli is rated as an Elite provider by MediFind in the treatment of Pancreatic Cancer. His top areas of expertise are Pancreatic Cancer, Anal Cancer, Familial Pancreatic Cancer, Pancreaticoduodenectomy, and Lymphadenectomy. Dr. Tuli is currently accepting new patients.

Dr. William E. Fisher is Professor and Vice-Chair for Clinical Affairs, Department of Surgery and the George L. Jordan, M.D. Chair in General Surgery at Baylor College of Medicine. Dr. Fisher also serves as Director of the Elkins Pancreas Center at BCM; and is Vice President, Medical Staff and Chief of the Surgery Service Line at Baylor St. Luke’s Medical Center.An internationally-known leader in pancreatic surgery, Dr. Fisher has focused entirely on surgery for pancreatic tumors and cysts in his practice for over 20 years and has extensive experience in advanced, minimally-invasive robotic pancreas surgery.Dr. Fisher’s professional interests include: pancreaticoduodenectomy (Whipple procedure); minimally invasive/laparoscopic/robotic pancreatic surgery; pancreas cancer; distal and central pancreatectomy; pancreas resection; surgical oncology; common bile duct resection; Puestow procedure; Frey procedure; and laparoscopic pancreatectomy.Dr. Fisher has served as PI of two NIH-funded multicenter randomized clinical trials that generated practice-changing impact on the use of drains during pancreatectomy, and the subsequent development of a multicenter pancreatic-surgery-outcomes consortium. His basic science lab has studied the influence of gastrointestinal hormones on pancreatic cancer growth, the relationship between diabetes and pancreatic cancer, and genomic analysis of pancreatic cancer, resulting in over 160 peer-reviewed publications.Having served as principal investigator on more than 15 clinical trials for patients with pancreatic cancer, Dr. Fisher is currently PI at BCM for the NIH Consortium to Study Chronic Pancreatitis, Diabetes and Pancreatic Cancer.Dr. Fisher received a B.A. from Wittenberg University and earned his medical degree from the University of Cincinnati College of Medicine.  He held a research fellowship and completed his residency at The Ohio State University.Among his numerous honors and awards, Dr. Fisher has been recognized as one of America’s Top Doctors for Cancer (Castle Connolly Medical Ltd.), Top 1% of Doctors in the U.S. (U.S. News and World Report), and “Texas Super Doctor” (Texas Monthly). He is also the recipient of the Master Clinician Award for Excellence in Patient Care from BCM and has twice received the DeBakey Distinguished Service Award from the Michael E. DeBakey Department of Surgery at BCM. Dr. Fisher is rated as an Elite provider by MediFind in the treatment of Pancreatic Cancer. His top areas of expertise are Chronic Pancreatitis, Pancreatic Cancer, Hereditary Pancreatitis, Pancreaticoduodenectomy, and Pancreatectomy.

Ali Maawy is a Surgical Oncologist and a General Surgeon in Corpus Christi, Texas. Dr. Maawy has been practicing medicine for over 17 years and is rated as an Elite provider by MediFind in the treatment of Pancreatic Cancer. His top areas of expertise are Pancreatic Cancer, Familial Pancreatic Cancer, Retroperitoneal Inflammation, Small Bowel Resection, and Bladder Reconstruction. Dr. Maawy is currently accepting new patients.

Dr. Kimberly Washington is fellowship-trained in hepato-pancreato-biliary surgery with vast experience in the surgical and non-surgical treatment of liver, pancreas and biliary tract disorders. She uses a variety of techniques, including minimally invasive laparoscopy, endoscopy, ablation and robotic-assisted approaches, in the management of benign pancreatic masses, acute/chronic pancreatitis and pancreatic cysts. She is also trained in the management of hepatocellular carcinoma, cholangiocarcinoma and all liver metastatic diseases. Additionally, she treats benign diseases of the liver and biliary tract, including hepatic adenomas, liver hemangiomas, polycystic liver disease, simple and complex biliary stone disease, and bile duct injuries.Dr. Washington earned her medical degree and completed general surgery residency at the University of Tennessee in Memphis. She then served the Arlington, Texas community as a board-certified general surgeon from 2014 until 2020. In 2020, she returned to training in hepato-pancreato-biliary surgery fellowship at Oregon Health & Science University in Portland.In addition to her dedication to the management of surgical disease, Dr. Washington has also served on a global scale, caring for patients in India, Peru, Guatemala and Kenya. She has and continues to serve on numerous regional and national committees to advance the treatment of hepato-pancreato-biliary diseases. Dr Washington has published peer-reviewed works on areas of special interest, including multi-disciplinary management of colorectal liver metastasis with node-negative primary disease and surgical management of breast cancer liver metastasis, presenting many of these published works at national and international meetings. Through her role as a faculty member with the TCU Burnett School of Medicine, Dr. Washington was recognized in 2024 with the Gachman Endowed Faculty Excellence Award. She is a member of the American College of Surgeons, Americas Hepato-Pancreato-Biliary Association, American Pancreatic Association, Association of Women Surgeons, International Hepato-Pancreato-Biliary Association, Society of Surgical Oncology and Society for Surgery of the Alimentary Tract. Dr. Washington is rated as an Advanced provider by MediFind in the treatment of Pancreatic Cancer. Her top areas of expertise are Familial Pancreatic Cancer, Pancreatic Cancer, Pancreatic Pseudocyst, Pancreatectomy, and Liver Embolization.

Daniel Von Hoff is an Oncologist in Dallas, Texas. Dr. Von Hoff is rated as an Elite provider by MediFind in the treatment of Pancreatic Cancer. His top areas of expertise are Pancreatic Cancer, Pancreatic Ductal Adenocarcinoma, Basal Cell Skin Cancer, and Agranulocytosis.

Milind Javle is an Oncologist in Houston, Texas. Dr. Javle is rated as an Elite provider by MediFind in the treatment of Pancreatic Cancer. His top areas of expertise are Cholangiocarcinoma (Bile Duct Cancer), Gallbladder Cancer, Pancreatic Cancer, Pancreaticoduodenectomy, and Hepato-Pancreato-Biliary Surgery.

Shubham Pant is a Hematologist Oncology specialist and a Hematologist in Houston, Texas. Dr. Pant is rated as an Elite provider by MediFind in the treatment of Pancreatic Cancer. His top areas of expertise are Pancreatic Ductal Adenocarcinoma, Pancreatic Cancer, Cholangiocarcinoma (Bile Duct Cancer), Hepato-Pancreato-Biliary Surgery, and Pancreatectomy.

Florencia Mcallister is an Oncologist in Houston, Texas. Dr. Mcallister is rated as an Elite provider by MediFind in the treatment of Pancreatic Cancer. Her top areas of expertise are Pancreatic Cancer, Familial Pancreatic Cancer, DICER1 Syndrome, Pancreatectomy, and Endoscopy.

Brandon Smaglo is an Oncologist in Houston, Texas. Dr. Smaglo is rated as an Elite provider by MediFind in the treatment of Pancreatic Cancer. His top areas of expertise are Pancreatic Cancer, Pancreatic Ductal Adenocarcinoma, Familial Pancreatic Cancer, Colorectal Cancer, and Pancreatectomy.

Michael Overman is an Oncologist in Houston, Texas. Dr. Overman is rated as an Elite provider by MediFind in the treatment of Pancreatic Cancer. His top areas of expertise are Colorectal Cancer, Appendix Cancer, Pancreatic Cancer, Pancreaticoduodenectomy, and Hepatectomy.

Carlos Becerra is a Hematologist in Dallas, Texas. Dr. Becerra is rated as an Elite provider by MediFind in the treatment of Pancreatic Cancer. His top areas of expertise are Pancreatic Cancer, Familial Pancreatic Cancer, Pancreatic Ductal Adenocarcinoma, and Colorectal Cancer.

Pankaj Singh is a Gastroenterologist in Temple, Texas. Dr. Singh is rated as an Elite provider by MediFind in the treatment of Pancreatic Cancer. His top areas of expertise are Pancreatic Cancer, Fractured Spine, Beta-Ketothiolase Deficiency, Laminectomy, and Spinal Fusion.

Manoop Bhutani is a Gastroenterologist in Houston, Texas. Dr. Bhutani is rated as an Elite provider by MediFind in the treatment of Pancreatic Cancer. His top areas of expertise are Esophageal Cancer, Pancreatic Cancer, Stomach Cancer, Endoscopy, and Colonoscopy.

Prajnan Das is a Radiation Oncologist in Houston, Texas. Dr. Das is rated as a Distinguished provider by MediFind in the treatment of Pancreatic Cancer. His top areas of expertise are Stomach Cancer, Anal Cancer, Pancreatic Cancer, Pancreaticoduodenectomy, and Endoscopy.

Emma Holliday is a Radiation Oncologist in League City, Texas. Dr. Holliday is rated as a Distinguished provider by MediFind in the treatment of Pancreatic Cancer. Her top areas of expertise are Anal Cancer, Pancreatic Cancer, Cholangiocarcinoma (Bile Duct Cancer), and Stomach Cancer.

Jason Fleming is a Surgical Oncologist and a General Surgeon in Dallas, Texas. Dr. Fleming is rated as a Distinguished provider by MediFind in the treatment of Pancreatic Cancer. His top areas of expertise are Pancreatic Cancer, Familial Pancreatic Cancer, Neuroendocrine Tumor, Pancreatectomy, and Small Bowel Resection.

Dr. Benjamin Musher is a medical oncologist specializing in gastrointestinal cancers. He is the Medical Director of Medical Oncology and Director of the Gastrointestinal Cancer Program at the Dan L Duncan Comprehensive Cancer Center at Baylor College of Medicine (BCM), where he also holds the Barry Smith Endowed Professorship.Dr. Musher received an AB in Social Studies from Harvard University and his MD with Honors from BCM. He completed his residency in internal medicine at the University of Washington’s Department of Medicine, where he was an attending physician. He was later an attending physician and fellow in the Division of Hematology-Oncology at the University of Pennsylvania.Dr. Musher received the Oncology Faculty Educator of the Year for six consecutive years and the Fulbright & Jaworski L.L.P. Faculty Excellence Award, which recognizes BCM faculty for excellence in teaching and evaluation. He has also been recognized with several awards for going above and beyond to deliver exceptional patient experiences; and was named a Top Doctor in 2015 by Houstonia Magazine.Dr. Musher is board-certified in Medical Oncology from the American Board of Internal Medicine and is a member of the American Society of Clinical Oncology. Dr. Musher is rated as a Distinguished provider by MediFind in the treatment of Pancreatic Cancer. His top areas of expertise are Pancreatic Cancer, Colorectal Cancer, Familial Pancreatic Cancer, and Familial Colorectal Cancer.